Comparing topical scabietic treatments will soon become extinct.
Burkhart
K M
KM
Burkhart
C N
CN
Burkhart
C G
CG
D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018118:Chloride Channels / Q000187:drug effects; D017277:Drug Approval; D006734:Horse Diseases / Q000188:drug therapy; D006736:Horses; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012532:Scabies / Q000188:drug therapy* / Q000662:veterinary; D014481:United States; D014486:United States Food and Drug Administration
D000871:Anthelmintics; D018118:Chloride Channels; D007559:Ivermectin